Paper9701253
Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa.
Lewin AS and 6 others. Nat Med, 1998. Cited by 341 papers, by iCite.
Cite this record
ConductScience Library. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Papers, record 9701253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9701253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Photoreceptor Cells | Major topic |
| Point Mutation | Major topic |
| RNA, Catalytic | Major topic |
| Retinitis Pigmentosa | Major topic |
| Rhodopsin | Major topic |
| Animals | |
| Animals, Genetically Modified | |
| Dependovirus | |
| Disease Models, Animal | |
| Genes, Dominant | |
| Genetic Therapy | |
| Histidine | |
| Proline | |
| Promoter Regions, Genetic | |
| Rats | |
| Rats, Sprague-Dawley | |
| Retinal Rod Photoreceptor Cells | |
| Rod Opsins |
Source PubMed
Cited by154
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 341 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42183349 | Halofantrine protects photoreceptors in multiple models of retinal degeneration. | Res Sq | 2026 | https://conductscience.org/library/papers/42183349 | PubMed |
| 40047098 | Adaptive changes in the visual cortex after photoreceptor degeneration in retinitis pigmentosa. | Histol Histopathol | 2025 | https://conductscience.org/library/papers/40047098 | PubMed |
| 38661530 | Disease modeling and pharmacological rescue of autosomal dominant retinitis pigmentosa associated with RHO copy number variation. | Elife | 2024 | https://conductscience.org/library/papers/38661530 | PubMed |
| 38500685 | Cell-cell interaction in the pathogenesis of inherited retinal diseases. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/38500685 | PubMed |
| 38108516 | CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa. | CRISPR J | 2023 | https://conductscience.org/library/papers/38108516 | PubMed |
| 38060327 | Structural and functional rescue of cones carrying the most common cone opsin C203R missense mutation. | JCI Insight | 2024 | https://conductscience.org/library/papers/38060327 | PubMed |
| 37837380 | CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model. | Exp Biol Med (Maywood) | 2023 | https://conductscience.org/library/papers/37837380 | PubMed |
| 36312296 | Pre- and postsynaptic alterations in the visual cortex of the P23H-1 retinal degeneration rat model. | Front Neuroanat | 2022 | https://conductscience.org/library/papers/36312296 | PubMed |
| 36258031 | Network biology analysis of P23H rhodopsin interactome identifies protein and mRNA quality control mechanisms. | Sci Rep | 2022 | https://conductscience.org/library/papers/36258031 | PubMed |
| 35693295 | Zebrafish models of inherited retinal dystrophies. | J Transl Genet Genom | 2022 | https://conductscience.org/library/papers/35693295 | PubMed |
| 35563274 | Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563274 | PubMed |
| 35456659 | AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35456659 | PubMed |
| 35275162 | Subcellular localization of mutant P23H rhodopsin in an RFP fusion knock-in mouse model of retinitis pigmentosa. | Dis Model Mech | 2022 | https://conductscience.org/library/papers/35275162 | PubMed |
| 35213024 | Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35213024 | PubMed |
| 34722588 | Gene Therapy in Inherited Retinal Diseases: An Update on Current State of the Art. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34722588 | PubMed |
| 34100444 | Pharmacological strategies for treating misfolded rhodopsin-associated autosomal dominant retinitis pigmentosa. | Neural Regen Res | 2022 | https://conductscience.org/library/papers/34100444 | PubMed |
| 33224023 | Photoreceptor Degeneration in Pro23His Transgenic Rats (Line 3) Involves Autophagic and Necroptotic Mechanisms. | Front Neurosci | 2020 | https://conductscience.org/library/papers/33224023 | PubMed |
| 33036185 | A Zebrafish Model of Retinitis Pigmentosa Shows Continuous Degeneration and Regeneration of Rod Photoreceptors. | Cells | 2020 | https://conductscience.org/library/papers/33036185 | PubMed |
| 32536017 | Pharmacological clearance of misfolded rhodopsin for the treatment of RHO-associated retinitis pigmentosa. | FASEB J | 2020 | https://conductscience.org/library/papers/32536017 | PubMed |
| 32196553 | AAV-mediated ERdj5 overexpression protects against P23H rhodopsin toxicity. | Hum Mol Genet | 2020 | https://conductscience.org/library/papers/32196553 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9701253
GET https://conductscience.org/api/papers/v1/9701253/cited_by?page=2